Skip to main content
PMC home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 1993 Dec;56(12):1259–1264. doi: 10.1136/jnnp.56.12.1259

Effect of age on treatment decisions in low-grade glioma.

C J Vecht 1
PMCID: PMC1015369  PMID: 8270922

Abstract

The proper treatment of low-grade glioma is unclear and major uncertainties include the timing of therapy, the need for extensive surgery, or the application of radiotherapy. Although prospective trials are in progress, it may be years before results become available, as the five-year survival of low-grade glioma is around 45% or more. Age is an important prognostic factor in malignant glioma, but its implications for decisions on treatment have not yet been addressed in guidelines. This review examines the interaction between age and the results of applied treatment, based on data from published series. The available evidence suggests that, in younger patients, whether treatment is started early or late does not seem to affect long-term survival substantially. For patients under 35 years of age, more radical surgery appears to be beneficial, while radiation does not seem to improve the outcome. For patients who are 35 years and older, surgery and radiotherapy seems to produce better survival rates. The age of the patients should therefore be considered when decisions on the treatment of supratentorial, non-pilocytic, low-grade gliomas. For patients under 35 years of age who have either epilepsy or a surgically inaccessible tumour, it is advisable to defer treatment. The tumour should be largely excised, if possible. Following any surgery, radiotherapy should be withheld in this age group. For patients over 35 years of age, early treatment, including biopsy or surgery followed by radiotherapy, should not be delayed. Because of more prolonged survival, and to prevent neurotoxicity, radiation fields should be limited to the tumour bed and not include the whole of the brain. Future trials need to establish whether age is a crucial factor in deciding the timing and extent of treatment in patients with low-grade glioma.

Full text

PDF
1261

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ammirati M., Vick N., Liao Y. L., Ciric I., Mikhael M. Effect of the extent of surgical resection on survival and quality of life in patients with supratentorial glioblastomas and anaplastic astrocytomas. Neurosurgery. 1987 Aug;21(2):201–206. doi: 10.1227/00006123-198708000-00012. [DOI] [PubMed] [Google Scholar]
  2. Cairncross J. G., Laperriere N. J. Low-grade glioma. To treat or not to treat? Arch Neurol. 1989 Nov;46(11):1238–1239. doi: 10.1001/archneur.1989.00520470106035. [DOI] [PubMed] [Google Scholar]
  3. Chamberlain M. C., Murovic J. A., Levin V. A. Absence of contrast enhancement on CT brain scans of patients with supratentorial malignant gliomas. Neurology. 1988 Sep;38(9):1371–1374. doi: 10.1212/wnl.38.9.1371. [DOI] [PubMed] [Google Scholar]
  4. Chang C. H., Horton J., Schoenfeld D., Salazer O., Perez-Tamayo R., Kramer S., Weinstein A., Nelson J. S., Tsukada Y. Comparison of postoperative radiotherapy and combined postoperative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas. A joint Radiation Therapy Oncology Group and Eastern Cooperative Oncology Group study. Cancer. 1983 Sep 15;52(6):997–1007. doi: 10.1002/1097-0142(19830915)52:6<997::aid-cncr2820520612>3.0.co;2-2. [DOI] [PubMed] [Google Scholar]
  5. Ciric I., Ammirati M., Vick N., Mikhael M. Supratentorial gliomas: surgical considerations and immediate postoperative results. Gross total resection versus partial resection. Neurosurgery. 1987 Jul;21(1):21–26. doi: 10.1227/00006123-198707000-00005. [DOI] [PubMed] [Google Scholar]
  6. Clark G. B., Henry J. M., McKeever P. E. Cerebral pilocytic astrocytoma. Cancer. 1985 Sep 1;56(5):1128–1133. doi: 10.1002/1097-0142(19850901)56:5<1128::aid-cncr2820560529>3.0.co;2-j. [DOI] [PubMed] [Google Scholar]
  7. Fadul C., Wood J., Thaler H., Galicich J., Patterson R. H., Jr, Posner J. B. Morbidity and mortality of craniotomy for excision of supratentorial gliomas. Neurology. 1988 Sep;38(9):1374–1379. doi: 10.1212/wnl.38.9.1374. [DOI] [PubMed] [Google Scholar]
  8. Fazekas J. T. Treatment of grades I and II brain astrocytomas. The role of radiotherapy. Int J Radiat Oncol Biol Phys. 1977 Jul-Aug;2(7-8):661–666. doi: 10.1016/0360-3016(77)90045-1. [DOI] [PubMed] [Google Scholar]
  9. Garcia D. M., Fulling K. H., Marks J. E. The value of radiation therapy in addition to surgery for astrocytomas of the adult cerebrum. Cancer. 1985 Mar 1;55(5):919–927. doi: 10.1002/1097-0142(19850301)55:5<919::aid-cncr2820550502>3.0.co;2-4. [DOI] [PubMed] [Google Scholar]
  10. Gjerris F., Klinken L. Long-term prognosis in children with benign cerebellar astrocytoma. J Neurosurg. 1978 Aug;49(2):179–184. doi: 10.3171/jns.1978.49.2.0179. [DOI] [PubMed] [Google Scholar]
  11. Green S. B., Byar D. P., Walker M. D., Pistenmaa D. A., Alexander E., Jr, Batzdorf U., Brooks W. H., Hunt W. E., Mealey J., Jr, Odom G. L. Comparisons of carmustine, procarbazine, and high-dose methylprednisolone as additions to surgery and radiotherapy for the treatment of malignant glioma. Cancer Treat Rep. 1983 Feb;67(2):121–132. [PubMed] [Google Scholar]
  12. Hochberg F. H., Slotnick B. Neuropsychologic impairment in astrocytoma survivors. Neurology. 1980 Feb;30(2):172–177. doi: 10.1212/wnl.30.2.172. [DOI] [PubMed] [Google Scholar]
  13. Hutton J. L., Smith D. F., Sandemann D., Foy P. M., Shaw M. D., Williams I. R., Chadwick D. W. Development of prognostic index for primary supratentorial intracerebral tumours. J Neurol Neurosurg Psychiatry. 1992 Apr;55(4):271–274. doi: 10.1136/jnnp.55.4.271. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Imperato J. P., Paleologos N. A., Vick N. A. Effects of treatment on long-term survivors with malignant astrocytomas. Ann Neurol. 1990 Dec;28(6):818–822. doi: 10.1002/ana.410280614. [DOI] [PubMed] [Google Scholar]
  15. Jennings M. T., Asadourian L. L., Jennings V. D., Shapiro J. R., Thaler H. T. Factor analysis of the immunophenotypes of astrocytomas and malignant gliomas: correlations with tumor grade and patient survival. J Neurooncol. 1990 Dec;9(3):265–273. doi: 10.1007/BF02341157. [DOI] [PubMed] [Google Scholar]
  16. Kristiansen K., Hagen S., Kollevold T., Torvik A., Holme I., Nesbakken R., Hatlevoll R., Lindgren M., Brun A., Lindgren S. Combined modality therapy of operated astrocytomas grade III and IV. Confirmation of the value of postoperative irradiation and lack of potentiation of bleomycin on survival time: a prospective multicenter trial of the Scandinavian Glioblastoma Study Group. Cancer. 1981 Feb 15;47(4):649–652. doi: 10.1002/1097-0142(19810215)47:4<649::aid-cncr2820470405>3.0.co;2-w. [DOI] [PubMed] [Google Scholar]
  17. Laws E. R., Jr, Taylor W. F., Clifton M. B., Okazaki H. Neurosurgical management of low-grade astrocytoma of the cerebral hemispheres. J Neurosurg. 1984 Oct;61(4):665–673. doi: 10.3171/jns.1984.61.4.0665. [DOI] [PubMed] [Google Scholar]
  18. Leibel S. A., Sheline G. E., Wara W. M., Boldrey E. B., Nielsen S. L. The role of radiation therapy in the treatment of astrocytomas. Cancer. 1975 Jun;35(6):1551–1557. doi: 10.1002/1097-0142(197506)35:6<1551::aid-cncr2820350612>3.0.co;2-v. [DOI] [PubMed] [Google Scholar]
  19. Lieberman A. N., Foo S. H., Ransohoff J., Wise A., George A., Gordon W., Walker R. Long term survival among patients with malignant brain tumors. Neurosurgery. 1982 Apr;10(4):450–453. doi: 10.1227/00006123-198204000-00006. [DOI] [PubMed] [Google Scholar]
  20. Medbery C. A., 3rd, Straus K. L., Steinberg S. M., Cotelingam J. D., Fisher W. S. Low-grade astrocytomas: treatment results and prognostic variables. Int J Radiat Oncol Biol Phys. 1988 Oct;15(4):837–841. doi: 10.1016/0360-3016(88)90115-0. [DOI] [PubMed] [Google Scholar]
  21. North C. A., North R. B., Epstein J. A., Piantadosi S., Wharam M. D. Low-grade cerebral astrocytomas. Survival and quality of life after radiation therapy. Cancer. 1990 Jul 1;66(1):6–14. doi: 10.1002/1097-0142(19900701)66:1<6::aid-cncr2820660103>3.0.co;2-f. [DOI] [PubMed] [Google Scholar]
  22. Palma L., Guidetti B. Cystic pilocytic astrocytomas of the cerebral hemispheres. Surgical experience with 51 cases and long-term results. J Neurosurg. 1985 Jun;62(6):811–815. doi: 10.3171/jns.1985.62.6.0811. [DOI] [PubMed] [Google Scholar]
  23. Piepmeier J. M. Observations on the current treatment of low-grade astrocytic tumors of the cerebral hemispheres. J Neurosurg. 1987 Aug;67(2):177–181. doi: 10.3171/jns.1987.67.2.0177. [DOI] [PubMed] [Google Scholar]
  24. Recht L. D., Lew R., Smith T. W. Suspected low-grade glioma: is deferring treatment safe? Ann Neurol. 1992 Apr;31(4):431–436. doi: 10.1002/ana.410310413. [DOI] [PubMed] [Google Scholar]
  25. Scanlon P. W., Taylor W. F. Radiotherapy of intracranial astrocytomas: analysis of 417 cases treated from 1960 through 1969. Neurosurgery. 1979 Sep;5(3):301–308. [PubMed] [Google Scholar]
  26. Shapiro W. R. Low-grade gliomas: when to treat? Ann Neurol. 1992 Apr;31(4):437–438. doi: 10.1002/ana.410310414. [DOI] [PubMed] [Google Scholar]
  27. Shaw E. G., Daumas-Duport C., Scheithauer B. W., Gilbertson D. T., O'Fallon J. R., Earle J. D., Laws E. R., Jr, Okazaki H. Radiation therapy in the management of low-grade supratentorial astrocytomas. J Neurosurg. 1989 Jun;70(6):853–861. doi: 10.3171/jns.1989.70.6.0853. [DOI] [PubMed] [Google Scholar]
  28. Shaw E. G. Low-grade gliomas: to treat or not to treat? A radiation oncologist's viewpoint. Arch Neurol. 1990 Oct;47(10):1138–1140. doi: 10.1001/archneur.1990.00530100108023. [DOI] [PubMed] [Google Scholar]
  29. Smith D. F., Hutton J. L., Sandemann D., Foy P. M., Shaw M. D., Williams I. R., Chadwick D. W. The prognosis of primary intracerebral tumours presenting with epilepsy: the outcome of medical and surgical management. J Neurol Neurosurg Psychiatry. 1991 Oct;54(10):915–920. doi: 10.1136/jnnp.54.10.915. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Soffietti R., Chiò A., Giordana M. T., Vasario E., Schiffer D. Prognostic factors in well-differentiated cerebral astrocytomas in the adult. Neurosurgery. 1989 May;24(5):686–692. doi: 10.1227/00006123-198905000-00005. [DOI] [PubMed] [Google Scholar]
  31. Vecht C. J., Avezaat C. J., van Putten W. L., Eijkenboom W. M., Stefanko S. Z. The influence of the extent of surgery on the neurological function and survival in malignant glioma. A retrospective analysis in 243 patients. J Neurol Neurosurg Psychiatry. 1990 Jun;53(6):466–471. doi: 10.1136/jnnp.53.6.466. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Walker M. D., Alexander E., Jr, Hunt W. E., MacCarty C. S., Mahaley M. S., Jr, Mealey J., Jr, Norrell H. A., Owens G., Ransohoff J., Wilson C. B. Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial. J Neurosurg. 1978 Sep;49(3):333–343. doi: 10.3171/jns.1978.49.3.0333. [DOI] [PubMed] [Google Scholar]
  33. Walker M. D., Green S. B., Byar D. P., Alexander E., Jr, Batzdorf U., Brooks W. H., Hunt W. E., MacCarty C. S., Mahaley M. S., Jr, Mealey J., Jr Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery. N Engl J Med. 1980 Dec 4;303(23):1323–1329. doi: 10.1056/NEJM198012043032303. [DOI] [PubMed] [Google Scholar]
  34. Wallner K. E., Gonzales M. F., Edwards M. S., Wara W. M., Sheline G. E. Treatment results of juvenile pilocytic astrocytoma. J Neurosurg. 1988 Aug;69(2):171–176. doi: 10.3171/jns.1988.69.2.0171. [DOI] [PubMed] [Google Scholar]
  35. Winston K., Gilles F. H., Leviton A., Fulchiero A. Cerebellar gliomas in children. J Natl Cancer Inst. 1977 Apr;58(4):833–838. doi: 10.1093/jnci/58.4.833. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES